Hossain Md Shahadat, Sansam Courtney G, Wittig Kimberlie A, Noble Tyler D, Boyd Kevin A, Sansam Christopher L
Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104.
Cell Cycle and Cancer Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104.
bioRxiv. 2025 Jun 11:2025.06.10.657920. doi: 10.1101/2025.06.10.657920.
Dormant replication origins help ensure complete genome duplication when replication forks stall, yet how these origins are activated remains poorly understood. Here, we identify a novel regulatory mechanism by which cyclin-dependent kinase (CDK) activity controls the abundance and chromatin recruitment of the origin firing factors TRESLIN and MTBP to promote dormant origin activation. Inhibition of WEE1 kinase during S phase increases CDK activity, which blocks the PCNA-dependent degradation of TRESLIN and enhances its chromatin association along with MTBP. This increased loading is required for elevated helicase recruitment and DNA synthesis under CDK-hyperactive conditions. These effects are reversed by CDK inhibition and depend on both TRESLIN and MTBP. We define a conserved sequence within TRESLIN required for its CDK-sensitive degradation. Significantly, the recruitment of TRESLIN-MTBP and loading of helicase exceed levels observed in unperturbed S phase, supporting a model in which dormant origin firing is actively upregulated through CDKmediated stabilization of the initiation machinery. These findings uncover a new control point in replication origin usage with implications for genome stability and therapeutic kinase inhibition.
休眠复制起点有助于在复制叉停滞时确保基因组的完全复制,但这些起点如何被激活仍知之甚少。在这里,我们确定了一种新的调控机制,即细胞周期蛋白依赖性激酶(CDK)活性通过控制起始因子TRESLIN和MTBP的丰度及染色质募集来促进休眠起点的激活。在S期抑制WEE1激酶会增加CDK活性,这会阻断TRESLIN依赖增殖细胞核抗原(PCNA)的降解,并增强其与MTBP一起的染色质结合。这种增加的装载量是在CDK高活性条件下增加解旋酶募集和DNA合成所必需的。这些效应可通过CDK抑制逆转,且依赖于TRESLIN和MTBP两者。我们确定了TRESLIN内其对CDK敏感降解所必需的保守序列。重要的是,TRESLIN-MTBP的募集和解旋酶的装载超过了在未受干扰的S期所观察到的水平,支持了一种模型,即通过CDK介导起始机制的稳定来积极上调休眠起点的激发。这些发现揭示了复制起点使用中的一个新控制点,对基因组稳定性和治疗性激酶抑制具有重要意义。
2025-1
2025-1
Public Health Res (Southampt). 2025-7